Delivery of tacrolimus with cationic lipid-assisted nanoparticles for ulcerative colitis therapy

作者：Wang, Ji-Long; Gan, Yun-Jiu; Iqbal, Shoaib; Jiang, Wei; Yuan, You-Yong; Wang, Jun

来源：Biomaterials Science, 2018, 6(7): 1916-1922.

DOI：10.1039/c8bm00463c

• POLYMERIC NANOPARTICLES
• RAPID-TRANSPORT
• DRUG
• INFLAMMATION
• MUCUS
• GENE
• OPTIMIZATION
• DIFFUSION
• OUTCOMES

Oral drug delivery with nanoparticles has demonstrated great potential for drugs with poor bioavailability. Efficient delivery is possible by overcoming both the mucus and epithelial barrier of the gastrointestinal tract (GIT). Cationic lipid-assisted nanoparticles (CLANs), which are composed of amphiphilic block copolymers and cationic lipids, have been well studied and have been proved beneficial for drug delivery. In this study, CLANs prepared by poly(ethylene glycol)-block-poly(lactic acid) (PEG-b-PLA) and 1,2-dioleoyl-3-trimethylammonium-propanechloride (DOTAP) or N,N-bis(2-hydroxyethyl)-N-methyl-N-(2-cholesteryl-oxycarbonyl aminoethyl)ammoniumbromide (BHEM-Chol) were used for oral delivery of tacrolimus (FK506) for ulcerative colitis treatment. The average size of these nanoparticles is around 110 nm and the zeta-potential is 35 mV. These nanoparticles maintained their size in buffer solutions of pH 1.2 and 6.8, and slowly release the encapsulated drug. CLANs can be accumulated in the colon and transported through the epithelium in the colitis model by dextran sulfate sodium salt (DSS), leading to attenuation of DSS-induced colitis.

• 出版日期2018-7
• 单位中国科学技术大学; 华南理工大学